login
  Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

Radiation exposure during coronary angiography via transradial or transfemoral approaches: Does operator experience matter?


Wednesday, 25 Jul 2012 16:53
Binita Shah
Binita Shah

By Binita Shah

 

Cumulative radiation exposure to both patients and operators has become a topic of great interest given the overall increased use of both cardiovascular and non-cardiovascular imaging modalities. This is all the more important with the increasing usage of multimodality imaging, including non-invasive (single-photon emission computed tomography, computed tomography angiography) and invasive procedures in patients with known or suspected coronary artery disease.

 

The risks of increased radiation exposure, in the short run, include dermatologic burns for patients and, in the long run, increased risk of malignancy for both patients and operators.

 

At the same time, there is a growing trend to perform invasive coronary procedures utilising the transradial approach due to decreased major bleeding complications and increased patient satisfaction compared with the transfemoral approach. However, there is a learning curve for transradial approach for coronary angiography and intervention, and it is associated with longer procedural and fluoroscopy times. Whether the increased risk of radiation exposure is seen in transradial compared with transfemoral cases when procedures are performed by experienced operators is less clearly defined.

 

A retrospective analysis of radiation exposure during coronary angiography via transradial versus transfemoral approach performed by experienced operators at the New York University Langone Medical Center was presented on 15 May during an oral abstract session of the 2012 EuroPCR meeting. In a contemporary cohort of 1,696 patients undergoing coronary angiography with or without percutaneous coronary intervention (PCI) by experienced operators, transradial approach was associated with higher radiation exposure when compared with transfemoral approach. Experienced operators were defined as operators performing more than 75 PCIs per year for at least five years with more than 95% of cases using one type of approach to access.

In the diagnostic coronary angiogram only cohort, the main measure of radiation exposure, dose area product (DAP), was significantly 20.3% higher in the transradial compared with the transfemoral approach group. Junior cardiology fellows meaningfully participate during diagnostic procedures, and, therefore, a sensitivity analysis was performed excluding cases with a junior fellow present. Although median DAP decreased by 3.9% in the transradial and 0.6% in the transfemoral approach group, radiation exposure still remained significantly higher with transradial approach when the analysis was limited to procedures performed by very experienced operators without a junior cardiology fellow present.

 

In the PCI cohort, the majority were elective cases undergoing ad-hoc PCI with very low complication rates in both groups. Although lesion and procedural characteristics were well-balanced between the transradial and transfemoral approach groups, DAP was significantly 27.6% higher in the transradial compared with transfemoral approach groups.

 

Although this is a retrospective analysis of a single centre experience, we demonstrate that even in the hands of experienced operators, the radiation exposure still remains higher when using transradial approach compared with transfemoral approach. This study is also one of the few large cohorts to focus on a group of experienced operators and measure DAP, a better estimate of patient radiation dose than fluoroscopy time, as the primary outcome of interest. While transradial procedures may have other advantages (reduced access site complications/bleeding), the amount of radiation administered should also be considered with this approach.


Binita Shah is an interventional cardiologist, New York University School of Medicine, New York, USA




Add New Comment

Most popular


Friday, 04 Jul 2014
A new study suggests that transradial access in patients with non-ST-segment elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention is associated with reduced bleeding ... Transradial access predicts survival in NSTEMI patients

CE mark approval for Agent drug-coated balloon
Friday, 25 Jul 2014
According to Boston Scientific, the Agent drug-coated balloon provides physicians with an additional alternative to treat both in-stent restenosis and de novo small vessel coronary disease. CE mark approval for Agent drug-coated balloon

Tuesday, 01 Jul 2014
The Spectranetics Corporation has announced that it has completed the acquisition of AngioScore for US$230 million in cash, along with additional contingent commercial and regulatory milestone ... Spectranetics completes acquisition of AngioScore

Features


New approach for aortic valve replacement is feasible
Friday, 04 Jul 2014
According to a report in The Journal of Thoracic and Cardiovascular Surgery, totally endoscopic aortic valve replacement (TEAVR) is technically feasible. Lead author of the report Marco Vola talks to ... New approach for aortic valve replacement is feasible

“Interventional cardiology is losing more than 50% of the talent pool”
Thursday, 05 Jun 2014
The Women Committee of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) has been set up to attain gender equality in interventional cardiology at the professional and ... “Interventional cardiology is losing more than 50% of the talent pool”

Profiles


David J Cohen
Wednesday, 04 Jun 2014
David J Cohen, director, Cardiovascular Research, Saint Luke’s Mid America Heart Institute, Kansas C... David J Cohen

Ashok Seth
Wednesday, 12 Feb 2014
Ashok Seth is the immediate past president of Cardiological Society of India and is the principal ... Ashok Seth

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions